News Novo sales up, but CEO warns of fresh US price crackdown Certain US states drafting new pricing legislation
News FDA experts back Novo Nordisk's key diabetes drug Novo hopes for blockbuster sales from semaglutide
News China to accept overseas clinical trial data The Chinese government has announced plans to accept data from clinical trials carried out overseas, in order to speed up approvals.
News No cardio protection indication for Novo's semaglutide - yet Danish pharma plans outcome trial to confirm benefits in SUSTAIN 6
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
